Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Bode

Showing results (51-60 of 600) with videos related to

Pageof 60
Sort By:
Expert Review of Cardiovascular Therapy|March 20, 2004
Use of GPIIb/IIIa inhibitors in cardiovascular medicineIngo Ahrens, Karlheinz Peter, Christoph Bode
Frontiers in Cardiovascular Medicine|October 30, 2016
SIRT3 in Cardiac Physiology and DiseaseChristoph Koentges, Christoph Bode, Heiko Bugger
Herz|April 9, 2010
[Constrictive pericarditis: etiology, diagnostic work-up, and therapy]Daniela Föll, Annette Geibel-Zehender, Christoph Bode
Resuscitation|May 2, 2017
Time matters in patients undergoing extracorporeal cardiopulmonary resuscitationDawid L Staudacher, Christoph Bode, Tobias Wengenmayer
Journal of Critical Care|February 8, 2016
Duration of extracorporeal membrane oxygenation is a poor predictor of hospital survivalDawid L Staudacher, Christoph Bode, Tobias Wengenmayer
Frontiers in Cardiovascular Medicine|May 13, 2022
Macrophages in Atheromatous Plaque Developmental StagesAlexander von Ehr, Christoph Bode, Ingo Hilgendorf
European Heart Journal|September 11, 2019
Anticoagulation and anaemia: old opponents from the era of VKA?Christoph Bode, Christoph B Olivier, Daniel Duerschmied
International Journal of Molecular Sciences|December 22, 2016
Diabetic Cardiomyopathy: Does the Type of Diabetes Matter?Maximilian E Hölscher, Christoph Bode, Heiko Bugger
Hamostaseologie|October 18, 2018
Anticoagulation in Atherosclerotic DiseaseSamer Al Said, Christoph Bode, Daniel Duerschmied
Herz|June 27, 2008
[Optimal platelet inhibition after coronary stent implantation. Current status]Sigmund Silber, Hans Martin Hoffmeister, Christoph Bode
Pageof 60

Showing results (51-60 of 600) with videos related to

Sort By:
Pageof 60
Expert Review of Cardiovascular Therapy|March 20, 2004
Use of GPIIb/IIIa inhibitors in cardiovascular medicineIngo Ahrens, Karlheinz Peter, Christoph Bode
Frontiers in Cardiovascular Medicine|October 30, 2016
SIRT3 in Cardiac Physiology and DiseaseChristoph Koentges, Christoph Bode, Heiko Bugger
Herz|April 9, 2010
[Constrictive pericarditis: etiology, diagnostic work-up, and therapy]Daniela Föll, Annette Geibel-Zehender, Christoph Bode
Resuscitation|May 2, 2017
Time matters in patients undergoing extracorporeal cardiopulmonary resuscitationDawid L Staudacher, Christoph Bode, Tobias Wengenmayer
Journal of Critical Care|February 8, 2016
Duration of extracorporeal membrane oxygenation is a poor predictor of hospital survivalDawid L Staudacher, Christoph Bode, Tobias Wengenmayer
Frontiers in Cardiovascular Medicine|May 13, 2022
Macrophages in Atheromatous Plaque Developmental StagesAlexander von Ehr, Christoph Bode, Ingo Hilgendorf
European Heart Journal|September 11, 2019
Anticoagulation and anaemia: old opponents from the era of VKA?Christoph Bode, Christoph B Olivier, Daniel Duerschmied
International Journal of Molecular Sciences|December 22, 2016
Diabetic Cardiomyopathy: Does the Type of Diabetes Matter?Maximilian E Hölscher, Christoph Bode, Heiko Bugger
Hamostaseologie|October 18, 2018
Anticoagulation in Atherosclerotic DiseaseSamer Al Said, Christoph Bode, Daniel Duerschmied
Herz|June 27, 2008
[Optimal platelet inhibition after coronary stent implantation. Current status]Sigmund Silber, Hans Martin Hoffmeister, Christoph Bode
Pageof 60